Thomas P Fraher

Title: Thomas P. Fraher: Innovator in Pharmaceutical Chemistry

Introduction

Thomas P. Fraher is a notable inventor based in Chicago, IL (US), recognized for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on innovative solid-state forms of compounds used in medical treatments. His work has significantly impacted the development of therapeutic agents.

Latest Patents

Fraher's latest patents include advancements in crystalline forms of the p38 kinase inhibitor N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole. These patents describe various anhydrous crystalline forms that exhibit improved physical stability and unique properties compared to other solid-state forms. Additionally, he has developed methods for preparing these crystalline forms and pharmaceutical compositions that utilize them for treating p38 kinase-mediated conditions. Another patent focuses on the preparation of chiral β-amino acid compounds and their derivatives, showcasing his expertise in complex chemical synthesis.

Career Highlights

Throughout his career, Thomas P. Fraher has worked with prominent companies such as G.D. Searle & Company and Pharmacia Corporation. His experience in these organizations has allowed him to refine his skills in pharmaceutical research and development, contributing to the advancement of innovative medical solutions.

Collaborations

Fraher has collaborated with notable colleagues, including James W. Malecha and Kimberley C. Allen. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical chemistry.

Conclusion

Thomas P. Fraher's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.